December 18, 2017 Comments Off on New patent expiration for Novartis drug EXFORGE Posted in: Uncategorized
Annual Drug Patent Expirations for EXFORGE Exforge is a drug marketed by Novartis and is included in two NDAs. It is available from three suppliers. There are four patents protecting…
The post New patent expiration for Novartis drug EXFORGE appea…
December 18, 2017 Comments Off on New patent expiration for Genentech Inc drug ESBRIET Posted in: Uncategorized
Annual Drug Patent Expirations for ESBRIET Esbriet is a drug marketed by Genentech Inc and is included in two NDAs. It is available from one supplier. There are twenty-one patents…
The post New patent expiration for Genentech Inc drug ESBRIET appeared …
